Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Belgian Genome Resource to Resolve Rare Diseases

NCT07051213 is registered in ClinicalTrials.gov with Universitaire Ziekenhuizen KU Leuven as lead sponsor.

NCT NCT07051213
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07051213 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Belgian Genome Resource to Resolve Rare Diseases
Lead sponsor
Universitaire Ziekenhuizen KU Leuven
Phase
Not applicable
Overall status
Completed
Start date
June 2, 2021
Completion date
January 31, 2025
Enrollment
567 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

developmental delay (disorder), dysmorphia, intellectual developmental disorder, malformations